What is Human?
Human is at the forefront of developing sophisticated wearable lower limb exoskeleton technology. Their system is engineered to support a full range of natural motion, enabling users to walk, maintain balance, and navigate complex terrains like inclines, declines, and stairs with unprecedented ease. The core of their innovation lies in miniaturized, versatile robotic joint technology for the hip, knee, and ankle, built upon patent-pending mechanisms. This unique design positions Human's exoskeleton as a versatile solution across multiple sectors, including mobility assistance, motion augmentation, robotic rehabilitation, the gaming industry, robotic surgery, and fall prevention.
How much funding has Human raised?
Human has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2023): $10M with participation from BENO Holding
Key Investors in Human
BENO Holding
BENO Holding, a firm specializing in light industrial real estate, has participated in this funding round. Their involvement suggests a potential interest in the operational or logistical aspects of scaling advanced manufacturing or technology deployment, aligning with their focus on efficient and balanced systems for long-term success.
What's next for Human?
With the recent major strategic investment and substantial total funding, Human is poised for significant expansion. The company's focus on advanced robotics and assistive technology, particularly its unique lower limb exoskeleton, suggests a trajectory towards scaling production and broadening market penetration. Future developments will likely involve refining the technology for diverse applications, forging strategic partnerships, and potentially exploring new therapeutic or augmentation use cases. This enterprise-level backing indicates strong investor confidence in Human's ability to lead the market in wearable robotics and mobility solutions.
See full Human company page
